Ribeiro, E.; Araújo, D.; Pereira, M.; Lopes, B.; Sousa, P.; Sousa, A.C.; Coelho, A.; Rêma, A.; Alvites, R.; Faria, F.;
et al. Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines. Biomedicines 2023, 11, 799.
https://doi.org/10.3390/biomedicines11030799
AMA Style
Ribeiro E, Araújo D, Pereira M, Lopes B, Sousa P, Sousa AC, Coelho A, Rêma A, Alvites R, Faria F,
et al. Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines. Biomedicines. 2023; 11(3):799.
https://doi.org/10.3390/biomedicines11030799
Chicago/Turabian Style
Ribeiro, Eduarda, Diana Araújo, Mariana Pereira, Bruna Lopes, PatrÃcia Sousa, Ana Catarina Sousa, André Coelho, Alexandra Rêma, Rui Alvites, Fátima Faria,
and et al. 2023. "Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines" Biomedicines 11, no. 3: 799.
https://doi.org/10.3390/biomedicines11030799
APA Style
Ribeiro, E., Araújo, D., Pereira, M., Lopes, B., Sousa, P., Sousa, A. C., Coelho, A., Rêma, A., Alvites, R., Faria, F., Oliveira, C., Porto, B., MaurÃcio, A. C., Amorim, I., & Vale, N.
(2023). Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines. Biomedicines, 11(3), 799.
https://doi.org/10.3390/biomedicines11030799